<unk>  is a central nervous system agent, cholinesterase inhibitor and anti glaucoma that is FDA approved for the treatment of clinical or toxic dosages of drugs capable of producing the anticholinergic syndrome.   Common adverse reactions include diaphoresis, abnormal defecation (diarrhea), excessive salivation and nausea and vomiting.
Physostigmine
Neostigmine
Pyridostigmine
Neostigmine methylsulfate
Thiocarboxime
Fomepizole
Pyridostigmine Bromide
Suxamethonium chloride